-
Aijun QiaoPrincipal InvestigatorResearch Directions
1. Identifying novel therapeutic targets for metabolic diseases, including Obesity, T2D and NAFLD;
2. Identifying and screen small molecules and chemicals for anti-diabetes;
3. Investigating the signaling networks between heart and fat contributing to the development and progress of cardiovascular diseases.
-
Chaoqun WangPrincipal InvestigatorResearch Directions
Lung injury and repair
-
Chen TiegenPrincipal InvestigatorResearch Directions
1.Novel synthetic methodologies (radical chemistry);
2.Total synthesis and structural modification of natural products;
3.Discovery of lead compounds and candidate compounds;
4.Construction of bioactive small molecules library.
-
Cheng LuoPrincipal InvestigatorResearch Directions
1. Computational drug design
2.Medicinal chemical biology
3.Medicinal chemistry
-
Dean GuoPrincipal InvestigatorResearch Directions
1. Phytochemical analysis of Chinese Materia Medica
2. Quality standard elaboration of Chinese Materia Medica
-
Guangsen ShiPrincipal InvestigatorResearch Directions
Circadian clock and Sleep
-
Guilong ZhaoPrincipal InvestigatorResearch Directions
With 14 years of experience of drug discovery and development, Dr. Zhao’s research interest mainly focuses on the discovery and development of novel drugs for the treatment of metabolic and central nervous system diseases as well as the novel organic process development involved in the drug development. Dr. Zhao has a multidisciplinary background of synthetic organic chemistry, pharmacology, medical science, regulatory affairs and intellectual property and a unique experience of running drug R&D program from beginning all the way to the stage of clinical trials.
-
Guoqin XiaPrincipal InvestigatorResearch Directions
1. Novel bio-compatible chemical transformations development, including those bond-forming reactions for carboxylic acids, hydroxyl groups, amines etc.
2. Modular asymmetric synthetic methodologies towards multi-cyclic fused heterocycles and screening of these chemical library.
3. Covalent inhibitors design, synthesis and screening for K-Ras mutation proteins.